- Headquarters
- Barcelona
- Employees
- 51–200
- Founded
- 2018
- Business Model
- B2B
- Website
- seqera.io
- Total Funding
- $55.7M
- Last Round
- $26.0M Series BMay 2025
- Rounds
- 3
About
Founded in 2018 as a spin-off from the Centre for Genomic Regulation in Barcelona, Seqera is the company behind Nextflow, the open-source workflow engine used by 100,000+ scientists globally. Seqera's platform centralizes data, orchestrates pipelines, and provides governance and reproducibility for pharma, genomics, and biotech organizations running complex computational workloads across AWS, GCP, and Azure.
Summary
Seqera Labs is a Biotech company based in Barcelona, Spain, founded in 2018. It has raised $55.7M in total across 3 rounds, most recently a $26.0M Series B round in May 2025. Investors include Speedinvest, Talis Capital and Addition.
Tech & App Stack
5 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
May 2025
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Novel DNA sequencing architecture to scale the ultra low cost whole genome
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
Long-read DNA sequencing company providing advanced systems for complete and accurate genome, tra...

Biotechnology company developing multi-cancer early detection blood tests using high-intensity ge...

Develops Gene Writing technology and non-viral delivery to create in vivo genetic medicines for m...

Clinical-stage precision medicine company developing targeted therapies for immune-mediated infla...